Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer's disease models: a systematic review and meta-analysis of preclinical studies

• Asıl Yazarlar: Fanjing Kong (Yazar), Tianyu Wu (Yazar), Jingyi Dai (Yazar), Zhenwei Zhai (Yazar), Jie Cai (Yazar), Zhishan Zhu (Yazar), Ying Xu (Yazar), Tao Sun (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2023-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Alzheimer's disease (AD) is a degenerative disease of the nervous system. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a drug used to treat type 2 diabetes, have been shown to have neuroprotective effects. This systematic review and meta-analysis evaluated the effects and potential me...